[1] Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system[J]. Acta Neuropathol, 2007, 114:97-109.
[2] Greenfield JP, Castañeda Heredia A, George E, Kieran MW, Morales La Madrid A. Gliomatosis cerebri:a consensus summary report from the First International Gliomatosis cerebri Group Meeting, March 26-27, 2015, Paris, France[J]. Pediatr Blood Cancer, 2016, 63:2072-2077.
[3] Herrlinger U, Jones DTW, Glas M, Hattingen E, Gramatzki D, Stuplich M, Felsberg J, Bähr O, Gielen GH, Simon M, Wiewrodt D, Schabet M, Hovestadt V, Capper D, Steinbach JP, von Deimling A, Lichter P, Pfister SM, Weller M, Reifenberger G. Gliomatosis cerebri:no evidence for a separate brain tumor entity[J]. Acta Neuropathol, 2016, 131:309-319.
[4] Broniscer A, Chamdine O, Hwang S, Lin T, Pounds S, Onar-Thomas A, Shurtleff S, Allen S, Gajjar A, Northcott P, Orr BA. Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas[J]. Acta Neuropathol, 2016, 131:299-307.
[5] Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System:a summary[J]. Acta Neuropathol, 2016, 131:803-820.
[6] Hatanpaa KJ, Fuda F, Koduru P, Young K, Lega B, Chen W. Lymphomatosis cerebri:a diagnostic challenge[J]. JAMA Neurol, 2015, 72:1066-1067.
[7] Feldman L, Li Y, Ontaneda D. Primary CNS lymphoma initially diagnosed as vasculitis[J]. Neurol Clin Pract, 2020, 10:84-88.
[8] Izquierdo C, Velasco R, Vidal N, Sánchez JJ, Argyriou AA, Besora S, Graus F, Bruna J. Lymphomatosis cerebri:a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature[J]. Neuro Oncol, 2016, 18:707-715.
[9] Correale J, Gaitán MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis:from pathogenic mechanisms to treatment[J]. Brain, 2017, 140:527-546.
[10] Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica[J]. Lancet Neurol, 2007, 6:805-815.
[11] Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, Belman AL. Acute disseminated encephalomyelitis:updates on an inflammatory CNS syndrome[J]. Neurology, 2016, 87(9 Suppl 2):38-45.
[12] Salvarani C, Brown RD Jr, Hunder GG. Adult primary central nervous system vasculitis[J]. Lancet, 2012, 380:767-777.
[13] Dutra LA, de Souza AW, Grinberg-Dias G, Barsottini OG, Appenzeller S. Central nervous system vasculitis in adults:an update[J]. Autoimmun Rev, 2017, 16:123-131.
[14] Major EO, Yousry TA, Clifford DB. Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis:a decade of lessons learned[J]. Lancet Neurol, 2018, 17:467-480.
[15] Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus:clinical features and pathogenesis[J]. Lancet Neurol, 2010, 9:425-437.
[16] Labrune P, Lacroix C, Goutières F, de Laveaucoupet J, Chevalier P, Zerah M, Husson B, Landrieu P. Extensive brain calcifications, leukodystrophy, and formation of parenchymal cysts:a new progressive disorder due to diffuse cerebral microangiopathy[J]. Neurology, 1996, 46:1297-1301.
[17] Jenkinson EM, Rodero MP, Kasher PR, Uggenti C, Oojageer A, Goosey LC, Rose Y, Kershaw CJ, Urquhart JE, Williams SG,Bhaskar SS, O'Sullivan J, Baerlocher GM, Haubitz M, Aubert G, Barañano KW, Barnicoat AJ, Battini R, Berger A, Blair EM, Brunstrom-Hernandez JE, Buckard JA, Cassiman DM, Caumes R, Cordelli DM, De Waele LM, Fay AJ, Ferreira P, Fletcher NA, Fryer AE, Goel H, Hemingway CA, Henneke M, Hughes I, Jefferson RJ, Kumar R, Lagae L, Landrieu PG, Lourenço CM, Malpas TJ, Mehta SG, Metz I, Naidu S, Õunap K, Panzer A, Prabhakar P, Quaghebeur G, Schiffmann R, Sherr EH, Sinnathuray KR, Soh C, Stewart HS, Stone J, Van Esch H, Van Mol CE, Vanderver A, Wakeling EL, Whitney A, Pavitt GD, Griffiths-Jones S, Rice GI, Revy P, van der Knaap MS, Livingston JH, O'Keefe RT, Crow YJ. Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts[J]. Nat Genet, 2016, 48:1185-1192.
[18] Bonomo G, Monfrini E, Borellini L, Bonomo R, Arienti F, Saetti MC, Di Fonzo A, Locatelli M. Systemic involvement in adult-onset leukoencephalopathy with intracranial calcifications and cysts (Labrune syndrome) with a novel mutation of the SNORD118 gene[J]. Eur J Neurol, 2020, 27:2329-2332.
[19] Lynch DS, Zhang WJ, Lakshmanan R, Kinsella JA, Uzun GA, Karbay M, Tüfekçioglu Z, Hanagasi H, Burke G, Foulds N, Hammans SR, Bhattacharjee A, Wilson H, Adams M, Walker M, Nicoll JA, Chataway J, Fox N, Davagnanam I, Phadke R, Houlden H. Analysis of mutations in AARS2 in a series of CSF1R-negative patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia[J]. JAMA Neurol, 2016, 73:1433-1439.
[20] Sone J, Mori K, Inagaki T, Katsumata R, Takagi S, Yokoi S, Araki K, Kato T, Nakamura T, Koike H, Takashima H, Hashiguchi A, Kohno Y, Kurashige T, Kuriyama M, Takiyama Y, Tsuchiya M, Kitagawa N, Kawamoto M, Yoshimura H, Suto Y, Nakayasu H, Uehara N, Sugiyama H, Takahashi M, Kokubun N, Konno T, Katsuno M, Tanaka F, Iwasaki Y, Yoshida M, Sobue G. Clinicopathological features of adult-onset neuronal intranuclear inclusion disease[J]. Brain, 2016, 139(Pt 12):3170-3186.
[21] Bai HX, Zou Y, Lee AM, Lancaster E, Yang L. Diagnostic value and safety of brain biopsy in patients with cryptogenic neurological disease:a systematic review and meta-analysis of 831 cases[J]. Neurosurgery, 2015, 77:283-295.